News Tag: Newsletter

Assessing Adaptive Radiotherapy and Chemotherapy for Muscle-Invasive Bladder Cancer (NRG-GU015, The ARCHER Trial)

Read More

Reena Cecchini, PhD, Promoted to Research Associate Professor at the University of Pittsburgh

Read More

Testing Immunotherapy with Radiation Therapy for Patients with High-Risk, T1 Bladder Cancer (NRG-GU014, The PARRC Trial)

Read More

In Memoriam – Victor G. Vogel, MD, MHS, FACP

Read More

NRG-GY037 Aims to Advance Outcomes in High-Risk Cervical Cancer

Read More

PSC Column: Record Retention in Clinical Trials. . . . Where are they now?

Read More

FORTE Study Updates: September 2025

Read More

PSC: Short Form Consent: The Who, What, When, Where, Why & How’s

Read More